The growth of Viagra and its effect on the pharmaceutical landscape presents a intricate question for traders. While the early sales figures were impressive, the intellectual property has expired, leading to a deluge of off-brand alternatives that are eroding revenue. Moreover, the sector is facing challenges related to demographic trends and sh… Read More